Although the impacts of Saccharomyces cerevisiae on cancers are mentioned, data on its use in mice with cyclic GMP-AMP synthase deficiency (cGAS-/-) are even rarer. This evidence concerns the gene CGAS and hyperinsulinemic hypoglycemia, familial, 4.